Nirrin Technologies has filed a notice of an exempt offering of securities to raise $6,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Nirrin Technologies is raising up to $6,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Gregory Crescenzi played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Nirrin Technologies
Sensors and analytics enable connections between critical process parameters and critical quality attributes, and quality ultimately defines safety, predictability and cost-effectiveness. Nirrins mission is thus to design, develop, manufacture high quality sensor and integration technologies by understanding and exceeding the technical needs of our pharmaceutical development customers while providing outstanding customer satisfaction and most competitive and innovative solutions. Our goal is to meet that need and to transform the way that biologics are developed and manufactured.
To learn more about Nirrin Technologies, visit http://nirrin.tech/
Contact:
Gregory Crescenzi, Chief Executive Officer
508-404-8329
https://www.linkedin.com/in/greg-crescenzi/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.